00874.HK
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 12.86
+2.14%Margins
Gross margin
14.8%
EBITDA margin
4.0%
EBIT margin
3.1%
Net margin
2.8%
FCF margin
1.8%
5.6%
Return on equity
2.5%
Return on assets
3.9%
Return on invested capital
0.89x
Asset turnover
HKD 2.9B
Cash from operations
HKD 8.62
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026